{
    "2020-12-24": [
        [
            {
                "time": "2020-12-24",
                "original_text": "前三季度净利增速212%！5家优质公司纳入创50指数",
                "features": {
                    "keywords": [
                        "净利增速",
                        "优质公司",
                        "创50指数"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-12-24",
                "original_text": "贝达药业：BPI-21668片药品临床试验申请获得受理",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "BPI-21668",
                        "临床试验",
                        "申请受理"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-24",
                "original_text": "贝达药业（300558.SZ）：BPI-21668片药品临床试验申请获受理",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "300558.SZ",
                        "BPI-21668",
                        "临床试验",
                        "申请受理"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}